JAKE PARKINSON: Open Payments
NPI 1316719024 · KAYSVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 39 payments from 17 companies in 2025. Trend: 2023 $24 · 2024 $494 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 3 | $49 |
| Cranial Technologies, Inc | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| Dynavax Technologies Corporation | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Organon LLC | 2 | $23 |
Products named: CAPLYTA, JARDIANCE, TRELEGY ELLIPTA, SHINGRIX, NURTEC ODT, Doc Band, Heplisav-B, Wegovy.
Industry payments across UT — which companies pay providers there.
